10-propargyl-10-deazaaminopterin and Lymphoma

10-propargyl-10-deazaaminopterin has been researched along with Lymphoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
O'Connor, O; Zain, J	1
Moore, MA; O'Connor, O; She, Y; Sirotnak, FM; Wang, ES; Zelenetz, AD	1

Reviews

1 review(s) available for 10-propargyl-10-deazaaminopterin and Lymphoma

Article	Year
Pralatrexate: basic understanding and clinical development. Expert opinion on pharmacotherapy, 2010, Volume: 11, Issue:10 Topics: Aminopterin; Animals; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Drug Evaluation, Preclinical; Folic Acid Antagonists; Humans; Lung Neoplasms; Lymphoma; Neoplasms	2010

Other Studies

1 other study(ies) available for 10-propargyl-10-deazaaminopterin and Lymphoma

Article	Year
Activity of a novel anti-folate (PDX, 10-propargyl 10-deazaaminopterin) against human lymphoma is superior to methotrexate and correlates with tumor RFC-1 gene expression. Leukemia & lymphoma, 2003, Volume: 44, Issue:6 Topics: Aminopterin; Animals; Apoptosis; Cell Survival; Folic Acid Antagonists; Humans; Lymphoma; Methotrexate; Mice; Mice, Inbred NOD; Mice, SCID; Transplantation, Heterologous; Tumor Cells, Cultured	2003

Article

Year

Activity of a novel anti-folate (PDX, 10-propargyl 10-deazaaminopterin) against human lymphoma is superior to methotrexate and correlates with tumor RFC-1 gene expression.

Leukemia & lymphoma, 2003, Volume: 44, Issue:6

Topics: Aminopterin; Animals; Apoptosis; Cell Survival; Folic Acid Antagonists; Humans; Lymphoma; Methotrexate; Mice; Mice, Inbred NOD; Mice, SCID; Transplantation, Heterologous; Tumor Cells, Cultured

2003